The validation of threshold decision ruls and calculator for APhiG algoritm for clarification of prostate cancer staging before treatment

Author:

Sergeeva N. S.1ORCID,Skachkova T. E.2ORCID,Marshutina N. V.2ORCID,Nushko K. M.2ORCID,Shevchuk I. M.3ORCID,Nazirov M. R.3ORCID,Alekseev B. Ya.4ORCID,Pirogov S. A.5ORCID,Yurkov E. F.5ORCID,Gitis V. G.5ORCID,Kaprin A. D.4ORCID

Affiliation:

1. P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

2. P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia

3. N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia

4. National Medical Research Radiological Center, Ministry of Health of Russia

5. Institute for Information Transmission Problems (Kharkevich Institute), Russian Academy of Sciences

Abstract

Background. We have previously described an algorithm APhiG (Age of patients, Prostate health index and Gleason score), for staging of prostate cancer before treatment. The algorithm was developed by logistic regression on a training dataset and validated on a validation dataset (VD). Objective. Validation of threshold decision rules and a program for APhiG calculation on the VD.Materials and methods. ROC curve analysis on VD (83 cases).Results and conclusion. It was shown that sensitivity, specificity, positive and negative predictive value, diagnostic accuracy threshold decision rules and area under the curve (AUC) for APhiG in the VD (n = 83) not significantly different from those indicators in the training dataset (n = 337), which was the basis for the algorithm APhiG development.

Publisher

Publishing House ABV Press

Subject

Urology,Nephrology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference12 articles.

1. Volchenko N.N., Kaprin A.D., Belyakov M.M., Petrov A.N. Comparative analysis of the degree of differentiation of prostate cancer on biopsy and surgical materials. Oncology. Journal them. P.A. Herzen 2016; 1 (5): 18-22. (In Russ.)

2. Tsui K., Shen B., Sun G. et al. Probability based diagnostic biopsy specimens as predictors of tumor grade and stage found. . Syst Bio Reprod Med 2004; 50(5): 333-337.

3. Lukyanov I.V. The difficulties of staging prostate cancer. Cancer Urology. 2013; 9(1):10-16. (In Russ.).

4. Tosoian J.J., Mamawala M., Epstein J.I. et al. Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer J Clin Oncol. 2015; 33(30): 3379-85.

5. Guazzoni G., Lazzeri M., Nava L. et al. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Eur Urol. 2012; 61(3): 455-66.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3